Treatment of Peptic Ulcers Caused by Helicobacter pylori
- 4 February 1993
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (5), 349-350
- https://doi.org/10.1056/nejm199302043280512
Abstract
Research on the pathogenesis and treatment of peptic ulcer disease is yielding surprising discoveries that will change the medical approach to ulcer therapy. Among the most surprising is the fact that peptic ulcer disease is often a curable infectious disorder.We now recognize three major causes of peptic ulcer disease: Helicobacter pylori infection, the use of nonsteroidal antiinflammatory drugs (NSAIDs), and pathologic hypersecretory states such as the Zollinger-Ellison syndrome1. Although the mechanisms of ulcer formation by H. pylori remain obscure, the results of the trial reported by Hentschel et al. in this issue of the Journal2 and also those . . .Keywords
This publication has 7 references indexed in Scilit:
- Effect of Ranitidine and Amoxicillin plus Metronidazole on the Eradication of Helicobacter pylori and the Recurrence of Duodenal UlcerNew England Journal of Medicine, 1993
- Difference in expression of Helicobacter pylori gastritis in antrum and bodyGastroenterology, 1992
- Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal UlcerAnnals of Internal Medicine, 1992
- I. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer diseaseJournal of Gastroenterology and Hepatology, 1991
- Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 1991
- Helicobacter pyloriPublished by Springer Nature ,1991
- Prevention of Gastroduodenal Injury Induced by Chromic Nonsteroidal Antiinflammatory Drug TherapyGastroenterology, 1989